Health Point Inc. Recognized For Life Extending Research


Posted February 5, 2014 by reginaldanderson

Health Point Inc. announced this week that the company is the recipient of international recognition for its stem cell research, widely acknowledged to directly contribute to research which will extend human life expectancy.
 
As a company specializing in the development, manufacture and supply of stem cells for basic research, Health Point Inc. has supported and promoted the research of hundreds of clinical research teams around the globe. Most of this research is in therapeutic development for the treatment of various diseases and conditions that shorten human life expectancy.

The company utilizes what it calls creative stem cell-based technology and other developed proprietary methods in the field of regenerative medicine. These techniques are leading to revolutionary drug discovery and life-changing therapies. Health Point Inc. has announced an initial public offering (IPO) in mid-2014 to fund facility expansion to meet the high level of demand.

Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at healthpointincorporated.com.

Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.

The information contained in this release is provided on an errors and omissions excepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at healthpointincorporated.com and other sources before making any material decisions.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Reginald Anderson
Phone 85281930750
Business Address 15/F Millennium City 5 (APM)
418 Kwun Tong Rd Central, Hong Kong
Country China
Categories Business , Research
Tags health , investment , manufacture , research , stem cells , supply
Last Updated February 5, 2014